Our Approach
LJI Associate Professor Sonia Sharma, Ph.D., investigates the biological basis of vasculitis, with the goal of guiding effective therapies. Dr. Sharma and her colleagues have found that the metabolic enzyme Adenosine Deaminase 2 (ADA2), which is mutated in DADA2 vasculitis, directly controls inflammatory immune responses. This finding opens the door to new treatments for vascular inflammation that could dampen pro-inflammatory immune responses in DADA2 and other similar vasculitis syndromes by correcting the metabolic defect caused by low ADA2 activity.
Sharma’s work is broadly useful for understanding chronic inflammatory conditions where vasculitis is often a key clinical complication.
Learn more: